Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Other Accumulated Expenses (2019 - 2025)

Updated

Pharming's Other Accumulated Expenses was $8.78 million in Q4 2025, up 48.2% from $5.92 million a year earlier.

Analysis

Pharming (PHAR) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

From Q4 2019 onward, Pharming has reported Other Accumulated Expenses for 12 quarters.

  • In earlier years, Other Accumulated Expenses was $5.92 million in FY2024 (+70.0%), $3.48 million in FY2023, -$1.58 million in FY2022 and -$625,000 in FY2021.
  • The Q4 2025 figure marks the highest quarterly Other Accumulated Expenses in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8.78 Mn
Dec 31, 2024 5.92 Mn
Dec 31, 2023 -1.08 Mn
Sep 30, 2023 -1.13 Mn
Jun 30, 2023 -1.74 Mn
Dec 31, 2022 -1.58 Mn
Dec 31, 2021 505,635.16
Sep 30, 2021 272,000.00
Jun 30, 2021 229,000.00
Dec 31, 2020 -1,694.24
Sep 30, 2020 2.49 Mn
Dec 31, 2019 -1.60 Mn
API Access

Pharming Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PHAR&period=max&api_key=YOUR_API_KEY